DBVT Q3 2017 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$495M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+8.9% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$44M-2307.8% margin

Net Income

-$44M-2347.3% margin

EPS (Diluted)

$-8.95

QoQ Revenue Growth

-48.2%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$37M

Stock-Based Comp.

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+8.9%
Gross Profit	$2M	$993,542	+90.4%
Operating Income	-$44M	-$37M	-16.6%
Net Income	-$44M	-$37M	-21.5%